Page 102 - Programme book for The International Liver Congress 2015, EASL ILC 2015

SATURDAY, APRIL 25, 2015

Parallel Session: Liver Transplantation Strauss 2

Chairs:
Gabriela Berlakovich, Austria
Patrizia Burra, Italy

SCIENTIFIC PROGRAMME ABSTRACT PREDICTIVE MODEL FOR THE NEED FOR LIVER
O104 TRANSPLANTATION IN SYMPTOMATIC POLYCYSTIC
11:30 - 11:45 LIVER DISEASE
Frederik Temmerman, Belgium
ABSTRACT
O105 COMPARISON OF SHORT-TERM AND LONG-TERM
11:45 - 12:00 OUTCOMES AFTER DCD AND DBD DONOR LIVER
TRANSPLANTATION
ABSTRACT Wayel Jassem, The United Kingdom
O106
12:00 - 12:15 THERAPEUTIC PLASMA EXCHANGE MODULATES
INNATE IMMUNE ACTIVATION AND IMPROVES
ABSTRACT OUTCOME IN PATIENTS WITH ACUTE LIVER FAILURE
O107 Christine Bernsmeier, The United Kingdom
12:15 - 12:30
IL-22 SECRETION IS REQUIRED FOR LIVER
ABSTRACT REGENERATION AND IS MODULATED BY
O108 EXTRACELLULAR NUCLEOTIDES
12:30 - 12:45 Guido Beldi, Switzerland

ABSTRACT RESIDUAL HCV-RNA IN LIVER EXPLANTS FROM
O109 PATIENTS UNDERGOING SOFOSBUVIR AND
12:45 - 13:00 RIBAVIRIN TREATMENT WHILE AWAITING LIVER
TRANSPLANTATION IS NOT ASSOCIATED WITH HCV
RELAPSE
Martina Gambato, Spain

TREATMENT OF SEVERE HCV-RECURRENCE AFTER
LIVER TRANSPLANTATION USING SOFOSBUVIR-BASED
REGIMENS: THE ANRS CO23 CUPILT STUDY
Georges-Philippe Pageaux, France

102 The International Liver Congress™ 2015 • ILC Programme